Effects of lycopene on protein expression in human primary prostatic epithelial cells

Cancer Prevention Research

Volumn 6, Issue 5, 2013, Pages 419-427

  Qiu, Xi ^a   Yuan, Yang ^a   Vaishnav, Avani ^b   Tessel, Michael A ^b   Nonn, Larisa ^b   Van Breemen, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GLUTATHIONE S TRANSFERASE OMEGA 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; LYCOPENE; MAMMALIAN TARGET OF RAPAMYCIN; PLACEBO; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROTECTION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DOWN REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; UPREGULATION;

ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; CAROTENOIDS; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; PROSTATE; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCELLULAR FRACTIONS;

EID: 84877297242     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0364     Document Type: Article

References (49)

1. National Cancer Institute, Surveillance Epidemiology and End Results 2012; [Accessed 2012 Aug 10]. Available from: http://seer.cancer.gov/statfacts/ html/prost.html.
2. Morgan TM, Koreckij TD, Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets 2009; 9:237-49.
3. van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, et al. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res 2011; 4:711-8.
4. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274:532-8. (Pubitemid 19261144)
5. Riso P, Visioli F, Grande S, Guarnieri S, Gardana C, Simonetti P, et al. Effect of a tomato-based drink on markers of inflammation, immuno-modulation, and oxidative stress. J Agric Food Chem 2006; 54:2563-6.
6. Haseen F, Cantwell MM, O'Sullivan JM, Murray LJ. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis 2009; 12:325-32.
7. Hazai E, Bikadi Z, Zsila S, Lockwood SF. Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyl, and selected oxidative metabolites with 5-lipoxygenase. Biorg Med Chem 2006; 14:6859-67. (Pubitemid 44307652)
8. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 2000; 36: 101-11. (Pubitemid 30317841)
9. Chew BP, Park JS. Carotenoid action on the immune response. J Nutr 2004; 134:257S-261S. (Pubitemid 38057459)
10. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, et al. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005; 4:177-86. (Pubitemid 40268075)
11. Levy J, Bosin E, Feldman B, Giata Y, Miinstera A, Danilenkoa M, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995; 24: 257-66.
12. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr Cancer 1999; 33:159-64. (Pubitemid 29270003)
13. Zhang L-X, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991; 12:2109-14.
14. Palozza P, Parrone N, Simone R, Catalano A. Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention. Curr Med Chem 2011; 18:1846-60.
15. Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R, et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 2004; 18:1019-21. (Pubitemid 39561511)
16. Goo YA, Li Z, Pajkovic N, Shaffer S, Taylor G, Chen J, et al. Systematic investigation of lycopene effects in LNCaP cells by use of novel largescale proteomic analysis software. Proteomics Clin Appl 2007; 1: 513-23.
17. Uzgare AR, Xu Y, Isaacs JT. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem 2004; 91:196-205.
18. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science 2010; 329: 568-71.
19. Peehl DM. Growth of prostatic epithelial and stromal cells in vitro. In: Russell PJ, Jackson P, Kingsley EA, editors. Prostate Cancer Methods and Protocols. Totowa, NJ: Human Press; 2003. p. 41-57.
20. Liu A, Pajkovic N, Pang Y, Zhu D, Calamini B, Mesecar AL, et al. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol Cancer Ther 2006; 5:2879-85. (Pubitemid 44849015)
21. Xu H, Freitas MA. Mass Matrix: a database search program for rapid characterization of proteins and peptides from tandem mass spectrometry data. Proteomics 2009; 9:1548-55.
22. Xu H, Freitas MA. A mass accuracy sensitive probability based scoring algorithm for database searching of tandem mass spectrometry data. BMC Bioinformatics 2007; 8:133.
23. Armenta JM, Hoeschele I, Lazar IM. Differential protein expression analysis using stable isotope labeling and PQD linear ion trap MS technology. J Am Soc Mass Spectrom 2009; 20:1287-302.
24. Peehl DM. Are primary cultures realistic models of prostate cancer? J Cell Biochem 2004; 91:185-95.
25. Peehl DM. Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 2005; 12:19-47. (Pubitemid 40477086)
26. Wakasugi K, Schimmel P. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem 1999; 274:23155-9.
27. Suh KS, Mutoh M, Gerdes M, Crutchley JM, Mutoh T, Edwards LE, et al. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor a-induced apoptosis, and inhibits tumor growth. Cancer Res 2005; 65:562-71.
28. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000; 2:469-75.
29. Sarto C, Binz PA, Mocarelli P. Heat shock proteins in human cancer. Electrophoresis 2000; 21:1218-26. (Pubitemid 30230786)
30. Zhang B, Zhang Y, Dagher MC, Shacter E. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res 2005; 65:6054-62. (Pubitemid 40994389)
31. Zhang D, Li F, Weidner D, Mnjoyan ZH, Fujise K. Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin. J Biol Chem 2002; 277:37430-8.
32. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, et al. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Sci STKE 2002; 99:14976-81. (Pubitemid 35334595)
33. Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, et al. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res 2006; 12:5987-93. (Pubitemid 44703758)
34. Fanger GR, Widmann C, Porter AC, Sather S, Johnson GL, Vaillancourt RR. 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 1998; 273:3476-83. (Pubitemid 28109768)
35. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES, Cox ME. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 2007; 26:252-63. (Pubitemid 46477835)
36. Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 2004; 7:284-9. (Pubitemid 39299485)
37. Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 2002; 227:886-93. (Pubitemid 35340343)
38. Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R, et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer 2003; 47:40-7. (Pubitemid 38250434)
39. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 2003; 163:923-33. (Pubitemid 37040128)
40. Lee WH, Isaacs WB, Bova GS, Nelson WG. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997; 6:443-50. (Pubitemid 27270550)
41. Matos HR, Di Mascio P, Medeiros MH. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch Biochem Biophys 2000; 383:56-9.
42. Matos HR, Marques SA, Gomes OF, Silva AA, Heimann JC, Di Mascio P, et al. Lycopene and beta-carotene protect in vivo iron-induced oxidative stress damage in rat prostate. Braz J Med Biol Res 2006; 39:203-10.
43. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen RB, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001; 93:1872-9. (Pubitemid 34048654)
44. Wertz K. Lycopene effects contributing to prostate health. Nutr Cancer 2009; 61:775-83.
45. Jeong W, Chang TS, Boja ES, Fales HM, Rhee SG. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-{alpha} signaling pathways. Sci STKE 2004; 279:3151-9. (Pubitemid 38140547)
46. Kim GY, Kim JH, Ahn SC, Lee HJ, Moon DO, Lee CM, et al. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogenactivated protein kinases and nuclear factor-kappaB. Immunology 2004; 113:203-11.
47. Taplin ME. Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol 2007; 4:236-44.
48. Herzog A, Siler U, Spitzer V, Seifert N, Denelavas A, Hunziker PB, et al. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J 2005; 19: 272-4. (Pubitemid 40189279)
49. Obermuller-Jevic UC, Olano-Martin E, Corbacho AM, Eiserich JP, van der Vliet A, Valacchi G, et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 2003; 133: 3356-60. (Pubitemid 37409459)